Literature DB >> 18619906

Dermatomal scratching after intramedullary quisqualate injection: correlation with cutaneous denervation.

Kori L Brewer1, Jeung Woon Lee, Heather Downs, Anne Louise Oaklander, Robert P Yezierski.   

Abstract

UNLABELLED: Central nervous system lesions cause peripheral dysfunctions currently attributed to central cell death that compromises function of intact peripheral nerves. Injecting quisqualate (QUIS) into the rat spinal cord models spinal cord injury (SCI) and causes at-level scratching and self-injury. Such overgrooming was interpreted to model pain until patients with self-injurious scratching after SCI reported itch motivated scratching that was painless because of sensory loss. Because self-injurious scratching is difficult to explain by central mechanisms alone, we hypothesized that QUIS injections damage peripheral axons of at-level afferents. QUIS was injected into thoracic spinal cords of 18 Long-Evans rats. Animals were killed 3 days after overgrooming began or 14 days after injection. Spinal cord lesions were localized and DRG-immunolabeled for ATF-3. At-level and control skin samples were PGP9.5-immunabeled to quantify axons. Eighty-four percent of QUIS rats overgroomed. Skin in these regions had lost two-thirds of epidermal innervation as compared with controls (P < .001). Rats that overgroomed had 47% less axon-length than nongrooming rats (P = .006). The presence of ATF-3 immunolabeled neurons within diagnosis-related groups of QUIS rats indicated death of afferent cell bodies. Overgrooming after QUIS injections may not be due entirely to central changes. As in humans, self-injurious neuropathic scratching appeared to require loss of protective pain sensations in addition to peripheral denervation. PERSPECTIVE: This study suggests that intramedullary injection of quisqualic acid in rats causes death of at-level peripheral as well as central neurons. Self-injurious dermatomal scratching that develops in spinal-injured rats may reflect neuropathic itch and loss of protective pain sensations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619906      PMCID: PMC3128346          DOI: 10.1016/j.jpain.2008.05.010

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  42 in total

1.  A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus.

Authors:  A R Moller
Journal:  Am J Otol       Date:  1997-03

Review 2.  Chronic central pain after spinal cord injury.

Authors:  M D Christensen; C E Hulsebosch
Journal:  J Neurotrauma       Date:  1997-08       Impact factor: 5.269

3.  Compulsive targeted self-injurious behaviour in humans with neuropathic pain: a counterpart of animal autotomy? Four case reports and literature review.

Authors:  Angela Mailis
Journal:  Pain       Date:  1996-03       Impact factor: 6.961

4.  Cutaneous innervation density in the allodynic form of postherpetic neuralgia.

Authors:  M C Rowbotham; G Yosipovitch; M K Connolly; D Finlay; G Forde; H L Fields
Journal:  Neurobiol Dis       Date:  1996       Impact factor: 5.996

5.  Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model.

Authors:  P R Yezierski; S Liu; L G Ruenes; J K Kajander; L K Brewer
Journal:  Pain       Date:  1998-03       Impact factor: 6.961

6.  Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy.

Authors:  B G McCarthy; S T Hsieh; A Stocks; P Hauer; C Macko; D R Cornblath; J W Griffin; J C McArthur
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

Review 7.  Postherpetic neuralgia: irritable nociceptors and deafferentation.

Authors:  H L Fields; M Rowbotham; R Baron
Journal:  Neurobiol Dis       Date:  1998-10       Impact factor: 5.996

8.  Regional difference in epidermal thinning after skin denervation.

Authors:  H Y Chiang; I T Huang; W P Chen; H F Chien; C T Shun; Y C Chang; S T Hsieh
Journal:  Exp Neurol       Date:  1998-11       Impact factor: 5.330

9.  Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function.

Authors:  D A Simone; M Nolano; T Johnson; G Wendelschafer-Crabb; W R Kennedy
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

10.  Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage.

Authors:  A L Oaklander; K Romans; S Horasek; A Stocks; P Hauer; R A Meyer
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  9 in total

Review 1.  Neuropathic itch.

Authors:  Anne Louise Oaklander
Journal:  Semin Cutan Med Surg       Date:  2011-06

2.  Comparison of the spinal neuropathic pain induced by intraspinal injection of N-methyl-d-aspartate and quisquate in rats.

Authors:  Seong-Soo Choi; Kyung-Don Hahm; Hong-Gi Min; Jeong-Gil Leem
Journal:  J Korean Neurosurg Soc       Date:  2011-11-30

3.  Sensory stimulation prior to spinal cord injury induces post-injury dysesthesia in mice.

Authors:  Emily L Hoschouer; Taylor Finseth; Sharon Flinn; D Michele Basso; Lyn B Jakeman
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

4.  Pruritic and nociceptive sensations and dysesthesias from a spicule of cowhage.

Authors:  R H LaMotte; S G Shimada; B G Green; D Zelterman
Journal:  J Neurophysiol       Date:  2009-01-14       Impact factor: 2.714

5.  Central Pain from Excitotoxic Spinal Cord Injury Induced by Intraspinal NMDA Injection: A Pilot Study.

Authors:  Yeon Ju Leem; Jung Wha Joh; Kyoung Woon Joeng; Jeong Hun Suh; Jin Woo Shin; Jeong Gill Leem
Journal:  Korean J Pain       Date:  2010-05-31

6.  Scratching Responses to Epidermal Injury in C57BL/6, DBA/2, BALB/c, and CD1 Mice.

Authors:  Jennifer L Sargent; Christiane V Löhr; Helen E Diggs
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

7.  Predifferentiated GABAergic neural precursor transplants for alleviation of dysesthetic central pain following excitotoxic spinal cord injury.

Authors:  Jeung Woon Lee; Stanislava Jergova; Orion Furmanski; Shyam Gajavelli; Jacqueline Sagen
Journal:  Front Physiol       Date:  2012-05-31       Impact factor: 4.566

8.  PI3K mediated activation of GSK-3β reduces at-level primary afferent growth responses associated with excitotoxic spinal cord injury dysesthesias.

Authors:  Sonja K Bareiss; Elizabeth Dugan; Kori L Brewer
Journal:  Mol Pain       Date:  2015-06-21       Impact factor: 3.395

Review 9.  Neuropathic Itch: Routes to Clinical Diagnosis.

Authors:  Manuel Pedro Pereira; Henning Wiegmann; Konstantin Agelopoulos; Sonja Ständer
Journal:  Front Med (Lausanne)       Date:  2021-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.